Literature DB >> 17160357

Analysis of most common mutations R778G, R778L, R778W, I1102T and H1069Q in Indian Wilson disease patients: correlation between genotype/phenotype/copper ATPase activity.

Sandeep Kumar1, Baburam Thapa, Gurjit Kaur, Rajendra Prasad.   

Abstract

The present study was intended to estimate the frequencies of the most common mutations (R778L, R778W, R778G, I1102T and H1069Q) of ATP7B in Indian Wilson disease (WD) population and to explore the correlation between genotype/phenotype and copper ATPase activity. A total of 33 WD patients and their family members from North West states of India were examined. The H1069Q, R778W and R778L mutations were absent in these WD patients. R778W and I1102T mutations were present in 36% of WD patients. Family analysis for these mutations using PCR-RFLP documented 5 carriers and 2 asymptomatic WD patients. The copper ATPase activity in WD patients was significantly reduced (50%) than that of control individuals. No significant difference was observed in copper stimulated ATPase activity between homozygous (R778W/R778W, I1102T/I1102T) and compound heterozygous (R778W/unknown mutation, I1102T/unknown mutation) WD patients. Serum ceruloplasmin, serum copper levels were significantly lower in homozygous WD patients than that of compound heterozygous. However, no significant difference was observed in liver copper contents between heterozygous and homozygous patients. In conclusion, the data suggest that R778W and I1102T are most common mutations and provide the basis of genetic (PCR-RFLP) diagnostic tool for Indian WD patients as well as in siblings/parents where biochemical parameters are ambiguous.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17160357     DOI: 10.1007/s11010-005-9028-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Molecular analysis and diagnosis in Japanese patients with Wilson's disease.

Authors:  N Shimizu; H Nakazono; Y Takeshita; C Ikeda; H Fujii; A Watanabe; Y Yamaguchi; H Hemmi; H Shimatake; T Aoki
Journal:  Pediatr Int       Date:  1999-08       Impact factor: 1.524

2.  A practice guideline on Wilson disease.

Authors:  Eve A Roberts; Michael L Schilsky
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

3.  Two novel mutations (2976INSA, 4311insA) of ATP7B in a patient with Wilson's disease coexisting with glucose-6-phosphate dehydrogenase deficiency.

Authors:  Rajendra Prasad; Gurjit Kaur; Sandeep Kumar; Babu Ram Thapa
Journal:  J Gastroenterol Hepatol       Date:  2005-04       Impact factor: 4.029

4.  Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses.

Authors:  A B Shah; I Chernov; H T Zhang; B M Ross; K Das; S Lutsenko; E Parano; L Pavone; O Evgrafov; I A Ivanova-Smolenskaya; G Annerén; K Westermark; F H Urrutia; G K Penchaszadeh; I Sternlieb; I H Scheinberg; T C Gilliam; K Petrukhin
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

5.  Wilson's disease in adults with cirrhosis but no neurological abnormalities.

Authors:  D M Danks; G Metz; R Sewell; E J Prewett
Journal:  BMJ       Date:  1990-08-11

6.  High frequency of two mutations in codon 778 in exon 8 of the ATP7B gene in Taiwanese families with Wilson disease.

Authors:  L M Chuang; H P Wu; M H Jang; T R Wang; W C Sue; B J Lin; D W Cox; T Y Tai
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

7.  Genotype-phenotype interactions in Wilson's disease: insight from an Icelandic mutation.

Authors:  R Palsson; J G Jonasson; M Kristjansson; A Bodvarsson; R D Goldin; D W Cox; S Olafsson
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-04       Impact factor: 2.566

8.  Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease.

Authors:  Y Yamaguchi; M E Heiny; J D Gitlin
Journal:  Biochem Biophys Res Commun       Date:  1993-11-30       Impact factor: 3.575

9.  Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease.

Authors:  Xiao-Qing Liu; Ya-Fen Zhang; Tze-Tze Liu; Kwang-Jen Hsiao; Jian-Ming Zhang; Xue-Fan Gu; Ke-Rong Bao; Li-Hua Yu; Mei-Xian Wang
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

10.  Molecular characterization of wilson disease in the Sardinian population--evidence of a founder effect.

Authors:  G Loudianos; V Dessi; M Lovicu; A Angius; A Figus; F Lilliu; S De Virgiliis; A M Nurchi; A Deplano; P Moi; M Pirastu; A Cao
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

View more
  5 in total

Review 1.  The genetics of Wilson disease.

Authors:  Irene J Chang; Si Houn Hahn
Journal:  Handb Clin Neurol       Date:  2017

2.  Molecular pathogenesis of Wilson disease among Indians: a perspective on mutation spectrum in ATP7B gene, prevalent defects, clinical heterogeneity and implication towards diagnosis.

Authors:  Arnab Gupta; Ishita Chattopadhyay; Sumit Dey; Poonam Nasipuri; Shyamal K Das; Prasanta K Gangopadhyay; Kunal Ray
Journal:  Cell Mol Neurobiol       Date:  2007-09-02       Impact factor: 5.046

3.  Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.

Authors:  Sorina Georgiana Boaru; Uta Merle; Ricarda Uerlings; Astrid Zimmermann; Christa Flechtenmacher; Claudia Willheim; Elisabeth Eder; Peter Ferenci; Wolfgang Stremmel; Ralf Weiskirchen
Journal:  J Cell Mol Med       Date:  2015-02-20       Impact factor: 5.310

4.  A novel heterozygous carrier of ATP7B mutation with muscle weakness and tremor: A Chinese Case Report.

Authors:  Zhengxiang Zhang; Jiayi Liu; Wenjing Zheng; Qun Hou; Liping Zhang
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-12-01       Impact factor: 2.041

5.  Mutation analysis of the ATP7B gene and genotype-phenotype correlation in Chinese patients with Wilson disease.

Authors:  Mingming Li; Jing Ma; Wenlong Wang; Xu Yang; Kaizhong Luo
Journal:  BMC Gastroenterol       Date:  2021-09-01       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.